

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 50mg | 360 pills | £0.88 | £394.97 £315.97 Best Price | |
| 50mg | 180 pills | £0.94 | £211.68 £169.34 | |
| 50mg | 120 pills | £1.06 | £160.04 £128.04 | |
| 50mg | 90 pills | £1.21 | £135.52 £108.42 | |
| 50mg | 60 pills | £1.34 | £100.67 £80.53 | |
| 50mg | 30 pills | £1.41 | £52.91 £42.33 | |
| 100mg | 360 pills | £1.53 | £687.97 £550.38 Popular | |
| 100mg | 180 pills | £1.55 | £348.50 £278.80 | |
| 100mg | 120 pills | £1.58 | £237.49 £189.99 | |
| 100mg | 90 pills | £1.63 | £183.28 £146.62 | |
| 100mg | 60 pills | £1.67 | £125.19 £100.15 | |
| 100mg | 30 pills | £1.89 | £70.98 £56.78 |
Pletal is a medication that contains the active ingredient cilostazol, a phosphodiesterase-3 (PDE3) inhibitor used to improve walking distance in people with intermittent claudication due to peripheral arterial disease.
It belongs to a class of drugs that combines vasodilating effects with a mild anti-platelet action. In practice, this means it helps widen small blood vessels and can reduce the tendency of blood to clot, which supports better blood flow to the legs during activity.
The primary therapeutic aim is symptom relief: by improving blood flow to the leg muscles, many people experience less pain and cramping when walking, allowing longer and more comfortable activity before claudication symptoms appear. The medicine is taken by mouth in tablet form and is usually prescribed by a clinician after a full assessment of circulatory health.
In the UK context, Pletal may require a prescription depending on local rules. The decision rests with a clinician or pharmacist who can assess suitability based on medical history, current medicines, and overall risk/benefit. If you are unsure about access or eligibility, ask your GP or a licensed pharmacist for guidance.
The medicine is specifically used for intermittent claudication caused by peripheral arterial disease, a condition where narrowed arteries reduce blood flow to the legs during activity. It is not a cure for the underlying disease, but it can help manage symptoms and improve mobility.
People typically seek this treatment when leg pain or cramping limits walking and daily activities. The goal is to enable longer periods of walking before symptoms begin, along with improved leg muscle function during exertion.
Beyond the symptom focus, cilostazol has implications for cardiovascular risk management because it exerts a mild anti-platelet effect. This can influence decisions about concomitant use of other antiplatelet or anticoagulant therapies, which your clinician will weigh against bleeding risk.
In practice, the medicine is considered for adults with confirmed Peripheral Artery Disease whose symptoms interfere with everyday activities. A clinician will determine whether this option aligns with the overall treatment plan, including lifestyle changes, exercise therapy, and other medications.
Cilostazol works by inhibiting an enzyme called phosphodiesterase-3 (PDE3) in vascular smooth muscle and platelets. This action raises levels of a messenger molecule called cyclic adenosine monophosphate (cAMP) inside cells. Higher cAMP leads to two main effects: the blood vessels smooth muscle relaxes (vasodilation), and platelets are less likely to clump together.
When blood vessels in the legs dilate, blood can reach muscle tissue more readily during activity. At the same time, the slight anti-platelet effect reduces the tendency for small clots to form, which can further support steady blood flow. The net result is less ischemia (oxygen shortage) in leg muscles during walking, translating into better exercise tolerance for many people.
Framed differently, think of cilostazol as both a traffic controller and a mild traffic reducer: it opens up the lanes to improve flow while reducing the chance of minor jams forming in the vessels, helping the leg muscles work more efficiently under stress.
In all cases, the exact response can vary between individuals depending on underlying vascular health, other medications, and lifestyle factors. A clinician can monitor effectiveness and adjust plans as needed. If you have questions about how this mechanism overlaps with other therapies you are taking, discuss them with your pharmacist or doctor.
The dosing plan is determined by a clinician, but the usual approach involves taking the tablets twice daily with meals to minimise stomach upset and to help maintain steady levels in the bloodstream. Do not change the number of tablets or the timing without medical advice.
Take the medicine at the same times each day to help maintain consistent blood levels. If you forget a dose, take it as soon as you remember, unless it is nearly time for the next dose; in that case, skip the missed dose and resume your regular schedule. Do not double up to make up for a missed dose without medical guidance.
It is important to follow a plan laid out by your clinician. If you have trouble swallowing tablets, talk to a pharmacist about alternatives or splitting instructions. Do not stop taking the medicine suddenly without consulting a clinician, as a gradual plan may be needed to avoid a rebound effect or symptom return.
Foods interact with some medicines, and cilostazol can be affected by other drugs. The clinician may advise avoiding certain substances or adjusting timing around meals and other medications. Always read the patient information leaflet provided with your prescription and ask a pharmacist if anything is unclear, especially if you take other blood thinners or medicines that affect blood pressure or heart rhythm.
Contraindications are conditions or factors that make treatment unsuitable. In this section, the main cautions are outlined, but this list is not exhaustive. A clinician will assess your full medical history before prescribing cilostazol.
Do not take cilostazol if you have a known allergy to cilostazol or any of the inactive ingredients in the tablet. Allergic reactions can range from skin rashes to more serious symptoms and require immediate medical attention.
Avoid use if you have active major bleeding or certain bleeding disorders, as the antiplatelet-like effect could increase bleeding risk. Your clinician will weigh benefits against bleeding risk in such situations.
Severe heart failure or a history of certain heart rhythm problems may affect suitability, since cilostazol can influence heart rate and blood flow dynamics. If you have heart disease of any kind, discuss this with your doctor before starting therapy.
Severe hepatic impairment or significant kidney dysfunction may alter how the medicine is processed by the body. In these cases, the clinician may adjust treatment or choose an alternative therapy. If you have liver or kidney problems, disclose them fully before starting treatment.
Pregnancy or breastfeeding involves additional considerations. If you are pregnant, planning pregnancy, or breastfeeding, talk with your clinician about risks and alternatives. The medication’s safety in pregnancy has not been established for all scenarios, and a clinician will balance potential benefits against risks.
Before starting cilostazol, discuss your full medical history, including recent surgeries, bleeding disorders, or a history of stroke or heart attack. Certain conditions can influence how well the medicine works or how safe it is for you.
Common adverse effects such as headaches, dizziness, or abdominal discomfort may occur during the first weeks. If these symptoms persist or worsen, contact your clinician, as they may indicate intolerance or a need to adjust the plan.
If you notice unusual bruising, prolonged bleeding from minor cuts, or heavy menstrual bleeding, seek medical advice promptly. The drug’s mild antiplatelet effect can interact with other medications that affect clotting.
Monitor for symptoms suggesting heart-related issues, such as chest pain, shortness of breath, or fainting. Seek urgent medical help if these symptoms occur, as they may signal a serious event requiring immediate care.
Tell every healthcare professional you encounter that you are taking cilostazol. This includes dentists, as minor procedures can sometimes affect bleeding and the overall management of your condition. Your clinician may adjust treatment around other therapies to reduce risk.
All medicines carry a risk of side effects. Many people tolerate cilostazol well, but some experience adverse effects that can affect daily life or require medical attention.
Common side effects include headaches, dizziness, and stomach upset such as indigestion or diarrhoea. Some people notice palpitations or a feeling of warmth in the face or chest. These effects are usually mild and tend to improve with time or after dose adjustments.
Less common but more serious reactions may occur, including severe allergic responses or signs of significant bleeding. If you develop swelling, severe rash, breathing difficulties, or unusually heavy bleeding, contact a clinician or seek urgent medical help.
In rare cases, cilostazol can interact with other medicines to cause a change in heart rhythm or blood pressure. Always report any new symptoms, especially if you start a new drug, supplement, or herbal product. Your pharmacist can help assess potential interactions.
Interactions can affect how well cilostazol works or increase the risk of side effects. It is important to tell your clinician about all medicines you take, including over-the-counter drugs and supplements.
Some medicines can raise cilostazol levels in the blood, which may intensify side effects or bleeding risk. These include certain antifungals, antibiotics, and other drugs that affect liver enzymes. Your clinician may adjust timing or choose alternatives.
Concomitant use with other antiplatelet drugs, anticoagulants, or non-steroidal anti-inflammatory drugs (NSAIDs) can elevate bleeding risk. Do not start or change these medicines without medical supervision.
Food interactions are possible, with some evidence suggesting that large amounts of grapefruit juice or certain other foods may alter drug levels. If you routinely consume grapefruit or a similar product, discuss this with a pharmacist to assess potential risks. Always follow the instructions on the patient information leaflet and your clinician’s advice regarding meals around dosing.
Pregnancy requires careful consideration because the effects of cilostazol on a developing fetus are not fully established. In general, cilostazol is used only if clearly needed and after a thorough risk–benefit assessment by a clinician.
Breastfeeding while taking cilostazol is not well studied. If you are breastfeeding or plan to, discuss with your clinician to determine whether continuing treatment is appropriate or whether an alternative is preferable for your baby.
In any scenario, never start or stop a medication during pregnancy or breastfeeding without consulting a healthcare professional. The safest option is guided by a clinician who can monitor both maternal and infant health.
If pregnancy occurs while using cilostazol, contact a clinician promptly to review treatment options and determine the best course of action for you and the baby. Do not rely on self-directed changes in therapy in this context.
Below are common questions patients ask about cilostazol. If you have a question not listed here, speak with a pharmacist or your clinician for personalised guidance.
Some people notice improvements in walking tolerance after several weeks of treatment, while others may require longer before full benefit is evident. Individual responses vary based on the severity of disease, activity level, and how well the medication is tolerated. Regular follow-up with a clinician helps gauge progress and adjust the plan if needed.
If you miss a dose, take it as soon as you remember, unless it is almost time for the next scheduled dose. In that situation, skip the missed dose and resume your regular schedule. Do not double up to make up for a missed dose without medical advice.
Grapefruit and some other fruit juices can interact with medicines by affecting how the body processes them. This may alter cilostazol levels in the blood. If you regularly consume grapefruit, discuss this with a clinician or pharmacist to determine whether it needs to be limited or avoided.
Treatment duration is decided by a clinician based on symptoms, blood flow, and overall health. Some people use cilostazol for months or longer with regular reviews. Your clinician will reassess periodically to decide whether to continue, adjust, or stop therapy.
Combining cilostazol with other antiplatelet drugs can increase bleeding risk. Your clinician will consider existing therapy and balance benefits against potential harm. Do not start or stop antiplatelet medications on your own; seek professional guidance.
Long-term safety depends on individual health, response, and monitoring. Regular medical reviews help ensure ongoing benefit while watching for side effects or interactions. If concerns arise, a clinician may adjust the plan or explore alternatives.
Chest pain, shortness of breath, fainting, or other severe symptoms require urgent medical attention. Do not assume these are side effects of cilostazol; seek immediate help to rule out a serious condition.
Use during pregnancy or breastfeeding should only occur if clearly indicated by a clinician after careful risk assessment. If pregnancy occurs or is planned, or if you are breastfeeding, discuss options with your healthcare provider before continuing treatment.
Ongoing follow-up is usually recommended to monitor efficacy, tolerability, and any interactions with other medicines. Your clinician may schedule reviews every few months or sooner if you notice changes in symptoms or side effects.
Official patient information leaflets provided with the medicine contain comprehensive details about dosing, safety, and interactions. Your pharmacist and GP can also answer questions and help interpret the leaflet in the context of your health.
For authoritative guidance, consult the official patient information leaflet that accompanies the medicine. This document summarises indications, contraindications, dosing guidance, and potential drug interactions in plain language.
Your GP, nurse, or pharmacist is a primary source of personalised information. They can review your full medication list, discuss potential interactions, and tailor advice to your health status and lifestyle.
In the UK, community pharmacies are a convenient point of contact for medication questions and can offer confidential advice on how to take cilostazol safely. If you have questions about eligibility, access, or alternatives, request a medication review with your local pharmacist.
Always carry a current list of your medicines, including over-the-counter products and supplements, when you visit a healthcare professional. If there is any uncertainty about information you receive, seek a second opinion from a licensed clinician or consult the official leaflet for clarification. If symptoms worsen or you notice unexpected effects, seek medical attention promptly.
14–21 days. Free from £148.79 .
5–9 days. £22.32
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.